YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Pharma Ventures


August 30, 2013 | Pharma is getting more notice from venture capital these days. Clarus Ventures, for example, has backed three specific pharma projects including Phase III studies of an already-approved drug in a new indication. Wall Street Journal Blog
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.